PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsGlobal Blood Therapeutics
Global Blood Therapeutics(GBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OxbrytaVoxelotor2019-11-252032-2037
Anemia
,
Sickle cell anemia
,
Hemolytic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voxelotor
renal insufficiency
,
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
hypoxia
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
chronic renal insufficiency
,
kidney diseases
,
lung diseases
,
acute lung injury
,
lung injury
,
ulcer
,
leg ulcer
,
sickle cell anemia
,
anemia
Vitamin k
alzheimer disease
,
thrombosis
,
heart diseases
,
venous thrombosis
,
colorectal neoplasms
,
chronic kidney failure
,
kidney diseases
,
atrial fibrillation
,
venous thromboembolism
,
thromboembolism
,
acute coronary syndrome
,
syndrome
,
embolism
,
financial stress
,
hemorrhage
,
cardiovascular diseases
,
ischemic stroke
,
stroke
,
cerebral hemorrhage
,
vascular diseases
Menatetrenone
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
Retinol
psoriasis
,
hodgkin disease
,
neoplasms
,
pancreatic neoplasms
,
pancreatic ductal carcinoma
,
recurrence
,
colonic neoplasms
,
rectal neoplasms
,
carotid artery diseases
,
atherosclerosis
,
leukemia
,
hematologic neoplasms
,
sezary syndrome
,
b-cell chronic lymphocytic leukemia
,
prolymphocytic leukemia t-cell
,
t-cell lymphoma
,
prolymphocytic leukemia
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
prolymphocytic leukemia b-cell
,
renal cell carcinoma
,
kidney neoplasms
,
gastrointestinal neoplasms
,
biliary tract neoplasms
,
hypercholesterolemia
,
osteoporosis
,
dyslipidemias
,
hyperlipidemias
,
adenocarcinoma
,
colorectal neoplasms
,
hyperlipoproteinemias
,
esophageal neoplasms
,
postmenopausal osteoporosis
,
hyperlipoproteinemia type v
,
familial combined hyperlipidemia
,
stomach neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
carcinoma
,
esophageal squamous cell carcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
vitamin d deficiency
,
non-hodgkin lymphoma
,
lymphoma
,
hyperlipoproteinemia type ii
,
flushing
,
lipidoses
,
hiv infections
,
cardiovascular diseases
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
peripheral arterial disease
,
peripheral vascular diseases
,
heart transplantation
,
polycystic ovary syndrome
,
syndrome
,
hiv
,
atopic dermatitis
,
eczema
,
dermatitis
Carbendazim
sickle cell anemia
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use